arrow
M

Melody Cobleigh

Rush University
H指数:46
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Updated efficacy, safety and translational data from MARIO-3, a phase II open-label study evaluating a novel triplet combination of eganelisib (IPI-549), atezolizumab (atezo), and nabpaclitaxel (nab-pac) as first-line ( 1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)
2022-02-1510
PRE
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer
2022-01-1836
OA
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
2017-10-01162
OAAI